Abarelix
Generic Name: abarelix
Manufactured by SPECIALITY EUROPEAN. Dosage form: POWDER. Route: INTRAMUSCULAR. Active ingredients: ABARELIX (100MG/VIAL). Application: NDA021320.
Overview
Manufactured by SPECIALITY EUROPEAN. Dosage form: POWDER. Route: INTRAMUSCULAR. Active ingredients: ABARELIX (100MG/VIAL). Application: NDA021320.
Dosage
Available as powder for intramuscular use.
Related Medications
Esomeprazole Magnesium Delayed Release Capsules
esomeprazole magnesium delayed release capsules
11 DESCRIPTION The active ingredient in the proton pump inhibitor esomeprazole magnesium delayed-release capsules, USP for oral administration is bis (5-methoxy-2-[(S)-[(4-methoxy-3, 5-dimethyl-2-pyridinyl) methyl]sulfinyl]-1 H -benzimidazole-1-yl) magnesium trihydrate. Esomeprazole is the S- isomer of omeprazole, which is a mixture of the S- and R- isomers. (Initial U.S. approval of esomeprazole magnesium: 2001).
Orange Creamsicle Spf 15 Broad Spectrum Lip Balm
orange creamsicle spf 15 broad spectrum lip balm
Purpose Sunscreen
Levalbuterol Inhalation 0.31mg/3ml
levalbuterol inhalation 0.31mg/3ml
beta2-Adrenergic Agonist [EPC]
11 DESCRIPTION Levalbuterol Inhalation Solution, USP is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of levalbuterol, the (R)-enantiomer of the drug substance racemic albuterol. Levalbuterol HCl is a relatively selective beta 2 -adrenergic receptor agonist [see Clinical Pharmacology ( 12 )].
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.